Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
Authors
Keywords
Cancer therapy-induced cardiac injury, Preclinical models, Cardioprotection, Mitochondria, Neuregulin-1, Oxidative stress, Statins, Beta-blockers, ACE inhibitors, Cardiac stem cells
Journal
HEART FAILURE REVIEWS
Volume 20, Issue 5, Pages 621-631
Publisher
Springer Nature
Online
2015-07-14
DOI
10.1007/s10741-015-9497-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Embryonic Stem Cells and Released Factors Stimulate c-kit+/FLK-1+ Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy
- (2015) Dinender K. Singla et al. CELL TRANSPLANTATION
- Transplantation of Mesenchymal Cells Improves Peripheral Limb Ischemia in Diabetic Rats
- (2014) Rosalinda Madonna et al. MOLECULAR BIOTECHNOLOGY
- Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure
- (2014) Hilda Merino et al. PLoS One
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
- (2013) Sinziana Seicean et al. Circulation-Heart Failure
- The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors
- (2013) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy
- (2013) Hana Cernecka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
- (2013) Jonathan Welti et al. JOURNAL OF CLINICAL INVESTIGATION
- Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
- (2013) Xavier Bosch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stable Carbon Isotope Discrimination Is under Genetic Control in the C4 Species Maize with Several Genomic Regions Influencing Trait Expression
- (2013) S. Gresset et al. PLANT PHYSIOLOGY
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
- (2012) Siri Lagethon Heck et al. CARDIOLOGY
- Non-Invasive In Vivo Detection of Peripheral Limb Ischemia Improvement in the Rat After Adipose Tissue-Derived Stromal Cell Transplantation
- (2012) Rosalinda Madonna et al. CIRCULATION JOURNAL
- Neuregulin in Cardiovascular Development and Disease
- (2012) Oghenerukevwe Odiete et al. CIRCULATION RESEARCH
- Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
- (2012) Xiaoying Zhang et al. CIRCULATION RESEARCH
- Human umbilical cord mesenchymal stromal cells mitigate chemotherapy-associated tissue injury in a pre-clinical mouse model
- (2012) Guo-Hu Di et al. CYTOTHERAPY
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge
- (2012) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
- (2012) Mehmet G. Kaya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
- (2012) Sinziana Seicean et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Administration of Angiotensin-Converting Enzyme Inhibitors and -Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?
- (2012) S. Oliva et al. ONCOLOGIST
- Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
- (2011) Edith Pituskin et al. BMC CANCER
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
- (2011) Zeydin Acar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines
- (2010) D. Bovelli et al. ANNALS OF ONCOLOGY
- Hepatocyte growth factor/Met gene transfer in cardiac stem cells—potential for cardiac repair
- (2010) Rosalinda Madonna et al. BASIC RESEARCH IN CARDIOLOGY
- Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
- (2010) Xu Di et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Vitamin and Mineral Supplementation and Aspirin Use in Cancer Survivors
- (2010) Edward Giovannucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Troponin I Provides Insight Into Cardiotoxicity and the Anthracycline-Trastuzumab Interaction
- (2010) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Induced Cardiomyopathy
- (2010) Daniela Cardinale et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
- (2010) Amy V. Pointon et al. PLoS One
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
- (2009) A. Riad et al. CANCER RESEARCH
- Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
- (2009) Kevin Bersell et al. CELL
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
- (2009) Andrey Anisimov et al. CIRCULATION RESEARCH
- Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
- (2009) Risto Kerkela et al. CTS-Clinical and Translational Science
- Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction
- (2009) Lee W Jones et al. LANCET ONCOLOGY
- Evidence for Cardiomyocyte Renewal in Humans
- (2009) Olaf Bergmann et al. SCIENCE
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Cardiotoxicity Profile of Trastuzumab
- (2008) Steven M Ewer et al. DRUG SAFETY
- The role of Neuregulin-1β/ErbB signaling in the heart
- (2008) Laura Pentassuglia et al. EXPERIMENTAL CELL RESEARCH
- Dietary Supplement Use in Cancer Care: Help or Harm
- (2008) Mary L. Hardy HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of targeted angiogenic medicine
- (2008) S. LOGES et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- -Blockers alprenolol and carvedilol stimulate -arrestin-mediated EGFR transactivation
- (2008) I.-M. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myocardial Strain Analysis in a Doxorubicin-Induced Cardiomyopathy Model
- (2007) Elena Piegari et al. ULTRASOUND IN MEDICINE AND BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now